NRP1 and breast carcinoma: These results indicate that VEGF plays a role as an internal autocrine survival factor in breast cancer cells via VEGFR1 and not through VEGFR2 or NRP1, and suggest that the role of the VEGF/VEGFR1 axis in breast cancer cells may not be governed by the classical paradigm of signal transduction involving interaction between ligands and cell surface receptors.